Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Sandra Claes"'
Autor:
Tatiane Assone, Soraya Maria Menezes, Fernanda de Toledo Gonçalves, Victor Angelo Folgosi, Marcos Braz, Jerusa Smid, Michel E. Haziot, Rosa M. N. Marcusso, Flávia E. Dahy, Augusto César Penalva de Oliveira, Evelien Vanderlinden, Sandra Claes, Dirk Daelemans, Jurgen Vercauteren, Dominique Schols, Jorge Casseb, Johan Van Weyenbergh
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Human T-Lymphotropic Virus type-1 (HTLV-1) is a unique retrovirus associated with both leukemogenesis and a specific neuroinflammatory condition known as HTLV-1-Associated Myelopathy (HAM). Currently, most proposed HAM biomarkers require invasive CSF
Externí odkaz:
https://doaj.org/article/0069aec1fea641599c5da5254ed3985f
Autor:
Tobias Heigl, Janne Kaes, Celine Aelbrecht, Jef Serré, Yoshito Yamada, Vincent Geudens, Anke Van Herck, Arno Vanstapel, Annelore Sacreas, Sofie Ordies, Anna Frick, Berta Saez Gimenez, Jan Van Slambrouck, Hanne Beeckmans, Nilüfer A. Acet Oztürk, Michaela Orlitova, Annemie Vaneylen, Sandra Claes, Dominique Schols, Greetje Vande Velde, Jonas Schupp, Naftali Kaminski, Markus Boesch, Hannelie Korf, Schalk van der Merwe, Lieven Dupont, Jeroen Vanoirbeek, Laurent Godinas, Dirk E. Van Raemdonck, Wim Janssens, Ghislaine Gayan-Ramirez, Laurens J. Ceulemans, John E. McDonough, Erik K. Verbeken, Robin Vos, Bart M. Vanaudenaerde
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChronic rejection is a major complication post-transplantation. Within lung transplantation, chronic rejection was considered as airway centred. Chronic Lung Allograft Dysfunction (CLAD), defined to cover all late chronic complications, m
Externí odkaz:
https://doaj.org/article/523cb3938ed14de6b83dbb256d799395
Autor:
Tatiane Assone, Soraya Maria Menezes, Fernanda de Toledo Gonçalves, Victor Angelo Folgosi, Gabriela da Silva Prates, Tim Dierckx, Marcos Braz, Jerusa Smid, Michel E. Haziot, Rosa M. N. Marcusso, Flávia E. Dahy, Evelien Vanderlinden, Sandra Claes, Dominique Schols, Roberta Bruhn, Edward L. Murphy, Augusto César Penalva de Oliveira, Dirk Daelemans, Jurgen Vercauteren, Jorge Casseb, Johan Van Weyenbergh
Publikováno v:
Journal of Neuroinflammation, Vol 19, Iss 1, Pp 1-15 (2022)
Abstract Background HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is an incapacitating neuroinflammatory disorder for which no disease-modifying therapy is available, but corticosteroids provide some clinical benefit. Although H
Externí odkaz:
https://doaj.org/article/a1b1dbdb7e4045c0b20219ba3b828e15
Autor:
Anna Elisabeth Frick, Michaela Orlitová, Arno Vanstapel, Sofie Ordies, Sandra Claes, Dominique Schols, Tobias Heigl, Janne Kaes, Berta Saez-Gimenez, Robin Vos, Geert M. Verleden, Bart Vanaudenaerde, Stijn E. Verleden, Dirk E. Van Raemdonck, Arne P. Neyrinck
Publikováno v:
Intensive Care Medicine Experimental, Vol 9, Iss 1, Pp 1-15 (2021)
Abstract Background Primary graft dysfunction (PGD) remains a major obstacle after lung transplantation. Ischemia–reperfusion injury is a known contributor to the development of PGD following lung transplantation. We developed a novel approach to a
Externí odkaz:
https://doaj.org/article/61ba9a7e658b4ca3b6b58792f683221d
Autor:
Evelyn M. Covés-Datson, Steven R. King, Maureen Legendre, Michael D. Swanson, Auroni Gupta, Sandra Claes, Jennifer L. Meagher, Arnaud Boonen, Lihong Zhang, Birte Kalveram, Zoe Raglow, Alexander N. Freiberg, Mark Prichard, Jeanne A. Stuckey, Dominique Schols, David M. Markovitz
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Lectins, carbohydrate-binding proteins, have been regarded as potential antiviral agents, as some can bind glycans on viral surface glycoproteins and inactivate their functions. However, clinical development of lectins has been stalled by th
Externí odkaz:
https://doaj.org/article/283392a3b205412094e2427caa1508b6
Autor:
Max Van Hoof, Sandra Claes, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe
Publikováno v:
Molecules, Vol 28, Iss 5, p 2099 (2023)
Upregulated CXCR2 signalling is found in numerous inflammatory, autoimmune and neurodegenerative diseases, as well as in cancer. Consequently, CXCR2 antagonism is a promising therapeutic strategy for treatment of these disorders. We previously identi
Externí odkaz:
https://doaj.org/article/460cbb8f3c3e4770be67e2c1f11062b4
Autor:
Elisabet Van Loon, Baptiste Lamarthée, Thomas Barba, Sandra Claes, Maarten Coemans, Henriette de Loor, Marie-Paule Emonds, Priyanka Koshy, Dirk Kuypers, Paul Proost, Aleksandar Senev, Ben Sprangers, Claire Tinel, Olivier Thaunat, Amaryllis H. Van Craenenbroeck, Dominique Schols, Maarten Naesens
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite the critical role of cytokines in allograft rejection, the relation of peripheral blood cytokine profiles to clinical kidney transplant rejection has not been fully elucidated. We assessed 28 cytokines through multiplex assay in 293 blood sam
Externí odkaz:
https://doaj.org/article/ca8468521bab46df92009d2e8e9a7266
Publikováno v:
Viruses, Vol 14, Iss 5, p 951 (2022)
The emergence of new SARS-CoV-2 variants and the replacement of preceding isolates have been observed through B.1.1.7, B.1.351, B.1.617.2, and B.1.1.529 lineages (corresponding to alpha, beta, delta, and omicron variants of concern (VoC), respectivel
Externí odkaz:
https://doaj.org/article/46f0711737284bc78ab36553dae06150
Autor:
Roxanne Wouters, Sara Westrøm, Ann Vankerckhoven, Gitte Thirion, Jolien Ceusters, Sandra Claes, Dominique Schols, Tina B. Bønsdorff, Ignace Vergote, An Coosemans
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 687 (2022)
Novel treatment strategies are needed to provide a better prognosis for ovarian cancer. For this purpose, the current study was designed to evaluate the effects of different types of particle drug carriers on tumor response and on the tumor immune mi
Externí odkaz:
https://doaj.org/article/5f614b79901e4a00a523057f41007f26
Autor:
Christine De Bruyn, Jolien Ceusters, Chiara Landolfo, Thaïs Baert, Gitte Thirion, Sandra Claes, Ann Vankerckhoven, Roxanne Wouters, Dominique Schols, Dirk Timmerman, Ignace Vergote, An Coosemans
Publikováno v:
Cancers, Vol 13, Iss 23, p 5899 (2021)
In monotherapy, immunotherapy has a poor success rate in ovarian cancer. Upgrading to a successful combinatorial immunotherapy treatment implies knowledge of the immune changes that are induced by chemotherapy and surgery. Methodology: Patients with
Externí odkaz:
https://doaj.org/article/bb2e2b4915d248b390081c95fe13e742